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Astrocyte cultures prelabelled with PH]inositol were exposed to arachidonic acid (AA) in the presence and absence of various agonists. AA alone 
evoked a don-de~ndent increase in the a~umu~ation of inositol phosphates (IF), an effect not secondary to eicosanoid synthesis and release but 
which was abolished by EGTA. Separation of the IP revealed that AA stimulated increases in inositol tris-, bis- and monophosphates. IP formation 
evoked by carbachol or norepinephrine was additive with AA, whereas IP formation by platelet activating factor (PAF) or ATP was non-additive 
with AA. These results suggest hat AA released upon stimulation of astrocytes or other cells in the CNS could initiate and/or amplify intercellular 
signalhng. 
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1. INTRODUCTION 
Arachidonic acid (AA) is fundamental to a variety of 
biological functions. AA is a major component of 
membrane phospholipids, from which it can be 
liberated directly or indirectly by agonist activation of 
phospholipases, and serve as a precursor for subse- 
quent eicosanoid synthesis [11. AA is also implicated in 
the activation of protein kinase C (PKC), adenylate 
cyclase, and regulation of intracellul~ caIcium concen- 
tration 121. Support for AA and/or its metabolites as 
signal molecules has been boosted recently with the fin- 
ding that K+ charme opening in cardiac and smooth 
muscle is so regulated [3]. The proposal that AA itself 
is a signal molecule is attractive because in many in- 
stances agonist stimulation of phospholipases results in 
the liberation of free AA, in addition to eicosanoids 
141. AA is also implicated in CNS malfunctions. 
Associated with CNS trauma, there is a marked rise in 
free fatty acids, particularly in AA, which is considered 
to be a major mediator of ischemic cell injury 151, 
possibly in part through the ability of AA to interfere 
with mitochondrial respiration [6] and the effects of ox- 
ygen radicals involved in the metabolism of AA and 
eicosanoids [7]_ As AA itself appears to function as a 
signal molecule, it is possible that the high levels 
associated with trauma modify or disrupt normal inter- 
and intra-cellular signalling processes. 
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Prompted by earlier eports [8,9] that AA stimulates 
phosphoinositide (PPI) hydrolysis by activating 
phospholipase C (PLC), we have examined the effects 
of AA on primary cuhures of astrocytes, cells which 
liberate AA upon stimulation [l J and which have been 
well characterized in terms of receptor-linked PPI turn- 
over [lo]. AA directly stimulates the accumulation of 
inositol phosphates (IP) in these cells, and can amplify 
the IP response evoked by adrenergic and cholinergic 
receptor agonists. 
2. MATERIALS AND METHODS 
Astrocyte-enriched cultures were prepared from newborn rat 
cerebral cortex [I I] and grown to confluence (18 days in vitro) on 
$-well plates or in T75 flasks. Immunocytochemi~l chara~erization 
showed that these cuftures contained 9O-95% glial fibrillary acidic 
protein-positive cells. 
Breakdown of PPI was assessed, in cultures prelabelled with 
[3H]inositol, by how much intracellular ‘H-labelled inositol 
phosphates (‘HIP) accumulated in the presence of Li+. Cultures 
were prelabelled for 18 h in physidogicaJ saline solution (PSS) con- 
taining I $Xml myo-[2-3Hljnositol (20 Cilmmol, Amersham). 
Cultures were washed in PSS, preincubated for 15 min with 5 mM 
LiCI, and agonists were added for 30 min. Incubations were ter- 
minated by removal of the PSS and the addition of ice-cold 
methanol. The cells were harvested, and the ‘H-IP extracted and 
separated by ion exchange chromatography [II]. Aliquots of the 
organic phases also were taken to determine the incorporation into 
lipids, and ‘H recovered in IP was standardized to cpm in lipids. In 
some experiments the individual ‘HIP formed were determined. In- 
cubations were carried out in T75 flasks for 1 min in the absence of 
Li*. The labelled glycerophosphoinositol (GPI), inositol 
monophosphate (IPi), inositol bisphosphate (IPa), and inositot 
trisphosphate (IP3) were separated by ion-exchange chromatography 
and eluted with formate solutions of increasing strength [l t]. 
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Fig.1. Concentration dependence of AA-stimulated 3H-IP 
accumulation. Results, expressed as 9’0 basal IP accumulation, are 
means f SE from 5 experiments. 
3. RESULTS AND DISCUSSION 
Astrocyte cultures incubated with AA (as the free 
acid) show a concentration-dependent increase in the 
accumulation of 3H-IP (fig.I), which is two-times the 
basal value with 10 FM AA rising to six-times the basal 
value with 1OOpM AA. This effect is not due to the 
vehicle in which the AA is presented to the cells (0.3% 
ethanol, the maximal concentration achieved, is 
without effect on IP accumulation), and the effect per- 
sists when AA is presented to the cells bound to bovine 
serum albumin (data not shown). In experiments where 
cultures were incubated with 10 PM AA in the absence 
of calcium in the medium and in the presence of 
0.5 mM EGTA, IP accumulation was reduced from 
>200% to 120% of basal. Separation of the individu~ 
3H-IP formed in response to 10 FM AA (n = 3) showed 
increases (070 basal) in IP3 (143 rt 13), IP2 (I 32 + 5) and 
IPi (147 + 14), but not GPI (116 f 20) after 1 min of 
incubation in the absence of Li+. These responses were 
unaffected by EGTA. 
An earlier report [8] noted that AA stimulated the 
phosphatidylinositol phosphodiesterase and so caused 
the hydrolysis of PPI in a manner which was sensitive 
to calcium chelators. Zeitler and Handwerger [9] show- 
ed that 30 FM AA stimulated a marked increase in IPr 
in placental cells and though they could not detect 
changes in IP3, these authors suggested that the time 
course employed may have missed an initial burst of 
IP3 production. Volpi et al. [12], investigating the 
mechanism of AA-induced calcium mobilization in 
neutrophils, did not find any PPI hydrolysis with 5 pM 
AA. Our results are consistent with these data in that 
AA concentrations of 10 FM and above are required to 
evoke PPI hydrolysis, and long term IP accumulation 
is sensitive to calcium chelation. The mechanism by 
which AA evokes IP accumulation does not seem to re- 
quire AA entry into the bilayer as AA bound to BSA 
Fig.2. The effects of AA on ‘HIP accumulation in the presence of 
inhibitors of AA metabolism. AA, 10~M; INDO, indomethacin, 
5 &ml; NDGA, nordihydroguaiaretic acid, 5 PM. Results, 
expressed as 070 basal IP accumulation, are means + SE from 3 
experiments. 
has similar effects. The possibility of the effect being 
mediated by AA stimulation of PKC is additionally 
ruled out as these cells do not show accumulation of IP 
when exposed to agents (such as phorbol esters) which 
stimulate PKC directly [13]. The ability of AA to in- 
duce IP3 formation might explain the frequent observa- 
tion that AA induces intracellular calcium mobilization 
in numerous cell types, though we have yet to prove 
causality in astrocytes. 
As exogenous AA can drive the synthesis and release 
of eicosanoids from astrocytes, some of which (throm- 
boxane Az, prostaglandin Fza and various leukotrienes) 
evoke the hydrolysis of phosphoinositides [l], we were 
concerned that the effect of AA on IP accumulation 
could be secondary to its metabolism. Thus, astrocyte 
cultures were exposed to AA in the presence of in- 
domethacin and nordihydroguaiaretic acid, inhibitors 
TREATMENTS 
Fig.3. The effects of AA on agonist-evoked 3H-IP formation. AA, 
IO&M; ATP. 1OO~M; CARB, carbachol, 1OOpM; NE, 
norepinephrine, 100 PM; PAF, platelet activating factor, 100 pM. 
Resuhs, expressed as Vo basal IP accumulation, are means f SE from 
3-6 experiments. 
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of cyclooxygenase and lipoxygenase, respectively. As 
seen in fig.2, the effect of AA on IP accumulation per- 
sisted in the presence of these compounds, suggesting 
the response is due to a direct action of AA on PPI 
hydrolysis rather than the result of AA metabolism and 
eicosanoid release. 
In addition to the ability of AA alone to generate IP, 
we were interested to see the outcome of simultaneous 
presentation of AA with other PPI-hydrolyzing 
agonists. A variety of agonists timulate the turnover of 
PPI in astrocytes, including norepinephrine (NE) and 
carbachol [l 11, ATP [14] and platelet activating factor 
[ 151, and we have found that some combinations of 
agonists are additive, suggesting that receptors are link- 
ed to discrete pools of PPI, whereas other combina- 
tions are non-additive in their effects on IP 
accumulation. As seen in fig.3, treatment of astrocytes 
with AA, NE, carbachol, ATP and PAF stimulated the 
accumulation of IP with a rank order at these concen- 
trations of ATP % NE > carbachol = AA % PAF. 
Combinations of AA with carbachol or NE were ad- 
ditive with respect o IP accumulation, suggesting that 
separate PPI pools were involved. However, combina- 
tions of AA with ATP or PAF were non-additive, the 
response measured being that of the more effective 
agonist, and suggesting that AA competes with ATP 
and PAF for a common pool of PPI. 
Many cell types [ 16-191, including astrocytes [ 11, 
release AA together with its metabolites in response to 
stimulation. This AA could be destined for further pro- 
cessing (to eicosanoids) in neighboring cells [19,20], or 
it could represent a signal and induce responses in 
target cells [2]. The observation that AA evokes tur- 
nover of PPI and accumulation of IP (including IP3) in 
astrocytes, and also amplifies responses in these cells to 
certain other agonists, is suggestive vidence in favor of 
the hypothesis that AA itself can function directly as an 
intercellular signal in the CNS. In conditions such as 
ischemia or seizure when fatty acid levels are high 
(> IOO,UM), AA could disrupt normal intercellular 
signalling and so contribute to CNS dysfunction. 
The precise mechanism by which AA stimulates PPI 
hydrolysis remains to be determined. It is possible that 
AA interacts with an eicosanoid receptor linked to PPI 
hydrolysis, suggested by recent .findings of Naccache et 
al. [21] that part of the AA-induced mobilization of 
calcium in neutrophils is mediated by interaction of the 
fatty acid with the leukotriene B4 receptor. Evidence is 
therefore accumulating to suggest that AA be con- 
sidered an autacoid in its own right. 
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